Organization Overview
Alternative names
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
cd45-depleted allogenic peripheral blood stem cell (2 trials)
crizotinib (xalkori) (1 trial)
Anemia (Phase 3)
Anemia, Aplastic (Phase 3)
beta-Thalassemia (Phase 3)
Communicable Diseases (Phase 3)
Deficiency Diseases (Phase 2)
Graft vs Host Disease (Phase 3)
Granuloma (Phase 2)
Granuloma, Plasma Cell (Phase 3)
Granulomatous Disease, Chronic (Phase 2)
Hematologic Diseases (Phase 3)
Hepatoblastoma (Phase 3)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
Hodgkin Disease (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Lymphoma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Nijmegen Breakage Syndrome (Phase 2)
Opportunistic Infections (Phase 3)
Pancytopenia (Phase 2)
Sprains and Strains (Phase 2)
Syndrome (Phase 2)
Thalassemia (Phase 3)
Thrombocytopenia (Phase 2)
Wiskott-Aldrich Syndrome (Phase 2)